436
edits
Changes
→References
14. Jatiani, S.S. et al. (2010), JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies. Genes Cancer. 979-993. PMID 21442038 doi: 10.1177/1947601910397187
14. Jatiani, S.S. et al. (2010), JAK/STAT Pathways in Cytokine Signaling and Myeloproliferative Disorders: Approaches for Targeted Therapies. Genes Cancer. 979-993. PMID 21442038 doi: 10.1177/1947601910397187
15. Cross, NCP, and Reiter, A. (2002). Tyrosine kinase fusion genes in chronic myeloproliferative diseases. Leukemia. 16: 1207-1212. PMID 12094244 https://doi.org/10.1038/sj.leu.2402556
== Notes ==
== Notes ==
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.
<nowiki>*</nowiki>Primary authors will typically be those that initially create and complete the content of a page. If a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section, please contact the CCGA coordinators (contact information provided on the homepage). Additional global feedback or concerns are also welcome.